Biogen Inc. (IDP.DE) XETRA

Currency In EUR

AD

Valuation

Market Cap25.8B
Enterprise Value29.74B
P/E Ratio35.73
PEG Ratio-0.78
Price/Sales Ratio3.01
Price/Book Ratio1.59
Enterprise/Revenue3.73
Enterprise/EBITDA22.18

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.08
Operating Margin0.13
AD

Management Effectiveness

Return On Assets0.03
Return On Equity0.05

Income Statement

Revenue9.53B
Revenue/Share67.35
Gross Profit6.35B
EBITDA2.6B
Net Income1.29B
Diluted EPS8.79

Balance Sheet

Total Cash1.29B
Total Cash/Share8.7
Total Debt8.36B
Total Debt/Equity0.44
Current Ratio1.87
Book Value Per Share127.61

Price History

52-Week Change52.84
52-Week High192
52-Week Low103.75
Moving Average 50 Days158.78
Moving Average 200 Days146.02

Statistics

Average Volume388
Shares Outstanding147.75M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A
AD